Skip to content

LSD: all studies

Page 232 of 282: studies 2,311 to 2,320 of 2,815, newest first. Back to the LSD overview

Research

Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: high potency agonists at 5-HT2A receptors

Biochemical Pharmacology September 25, 2018 Amy J. Eshleman, Katherine M. Wolfrum, John F. Reed et al.

&NA; The use of new psychoactive substituted 2,5‐dimethoxy‐N‐benzylphenethylamines is associated with abuse and toxicity in the United States and elsewhere and their pharmacology is not well known. This study compares the mechanisms of action of 2‐(2,5‐dimethoxy‐4‐methylphenyl)‐N‐(2‐methoxybenzyl)ethanamine (25D‐NBOMe), 2‐(4‐ethyl‐2,5‐dimethoxyphenyl)‐N‐(2‐methoxybenzyl)ethanamine (25E‐NBOMe),...

The Final Configuration of Near-Death Experiences (1960–1975)

Oxford Scholarship Online September 20, 2018 Jens Schlieter

The final chapter of the discursive history outlines how Robert Crookall’s and Robert A. Monroe’s books on “astral projection,” but also C. G. Jung and other researchers discussing paranormal and parapsychological phenomena in the 1960s and early 1970s, already assembled almost all phenomena that Moody could bundle in 1975 under the new term “near-death experiences.” However, the chapter points...

Pushing Near-Death Experiences (III)

Oxford Scholarship Online September 20, 2018 Jens Schlieter 3 citations

The similarities between the experiences near death and drug experiences have often been stressed. This chapter goes a step further in providing evidence that the consumption of morphine, hashish, and especially more potent hallucinogens such as LSD in the 1960s and 1970s are to be identified as a major component, or “push factor,” of the emerging discourse on near-death. Not only were several...

Insomnia and inflammation: a two hit model of depression risk and prevention

World Psychiatry September 7, 2018 Michaela Irwin, D. Piber

tial impact of psychedelic drugs on psychiatry to that of the microscope on biology and, while this analogy may strike some as laughable, let us reflect for a moment that human research with psychedelics has been effectively moribund since the restrictive drug policy reforms of the 1960s-70s, and has only recently been revived. Classic serotonergic psychedelics – such as LSD, psilocybin and...

Psychedelics, Meditation, and Self-Consciousness

Frontiers in Psychology September 4, 2018 Raphaël Millière, Robin Carhart-Harris, Leor Roseman et al. 402 citations

In recent years, the scientific study of meditation and psychedelic drugs has seen remarkable developments. The increased focus on meditation in cognitive neuroscience has led to a cross-cultural classification of standard meditation styles validated by functional and structural neuroanatomical data. Meanwhile, the renaissance of psychedelic research has shed light on the neurophysiology of...

Decadance in the Late Middle Ages: The Case of Choreomania

August 21, 2018 Kathryn Emily Dickason 1 citation

In most scholarship, Choreomania conveys a context in which dance is inextricably linked to medicine. Choreomania , or dance mania (from the Greek terms choros , or dance, and mania , or madness), refers to the dance epidemics that swept Europe between the fourteenth and sixteenth centuries. During this time, French, Flemish and German chroniclers reported how hundreds of people erupted in...

Dark Classics in Chemical Neuroscience:N,N-Dimethyltryptamine (DMT)

ACS Chemical Neuroscience July 23, 2018 Lindsay P. Cameron, David E. Olson 114 citations

Though relatively obscure, N, N-dimethyltryptamine (DMT) is an important molecule in psychopharmacology as it is the archetype for all indole-containing serotonergic psychedelics. Its structure can be found embedded within those of better-known molecules such as lysergic acid diethylamide (LSD) and psilocybin. Unlike the latter two compounds, DMT is ubiquitous, being produced by a wide variety...

Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development

Frontiers in Pharmacology July 5, 2018 Eduardo Ekman Schenberg 242 citations

Mental disorders are rising while development of novel psychiatric medications is declining. This stall in innovation has also been linked with intense debates on the current diagnostics and explanations for mental disorders, together constituting a paradigmatic crisis. A radical innovation is psychedelic-assisted psychotherapy (PAP): professionally supervised use of ketamine, MDMA, psilocybin,...

Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress

International Review of Psychiatry July 4, 2018 Stephen Ross 103 citations

Cancer is highly prevalent and one of the leading causes of global morbidity and mortality. Psychological and existential suffering is common in cancer patients, associated with poor psychiatric and medical outcomes. Promising early-phase clinical research (1960s to early 1970s) suggested a therapeutic signal for serotoninergic psychedelics (e.g. psilocybin, LSD) in treating cancer-related...

Confrontational continuum: modernism and the psychedelic art of Martin Sharp

The Sixties July 3, 2018 Michael Organ

ABSTRACT The Australian artist Martin Sharp (1942–2013) produced a series of psychedelic artworks in London between 1966 and 1968, the most famous of which were the Disraeli Gears record cover for rock group Cream and the Bob Dylan Blowin’ in the Mind poster. Sharp’s work exemplifies the connection between early twentieth century Modernist art movements, Pop art and acid-induced psychedelia of...